Merck Data at ESMO 2018 Congress Highlight Multiple Therapeuti...
DARMSTADT, Germany, Oct. 9, 2018 /PRNewswire-AsiaNet/-- Not intended for distribution in the USA, Canada or UK ESMO Abstract #Avelumab: LBA6_PR, 659P, 1290P, 1291P, 1282P, 877P; M7824 (TGF beta-trap/anti-PD-L1) :1048O, 1463P, 1931P, 757P, 643P, 642P, 661P; tepotinib (MET kinas...
Read more https://view-release/?pr-id=75627